Bloomberg News

Top Canada Court Denies Pfizer Appeal over Apotex Glaucoma Drug

February 02, 2012

Feb. 2 (Bloomberg) -- The Supreme Court of Canada today denied an appeal by Pfizer Canada Inc. over a generic drug produced by Apotex Inc. to treat glaucoma.

Pfizer appealed to the Supreme Court after a lower court overturned an earlier order that had prevented Apotex from marketing a generic version of the drug Xalatan.

To contact the reporter on this story: Greg Quinn in Ottawa at gquinn1@bloomberg.net

To contact the editor responsible for this story: Paul Badertscher at pbadertscher@bloomberg.net


Reviving Keynes
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus